相似文献
1
SV119-gold nanocage conjugates: a new platform for targeting cancer cells via sigma-2 receptors.
Nanoscale. 2012 Jan 21;4(2):421-4. doi: 10.1039/c1nr11469g. Epub 2011 Nov 24.
2
Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies.
Adv Healthc Mater. 2014 Aug;3(8):1283-91. doi: 10.1002/adhm.201400026. Epub 2014 Mar 26.
3
Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy.
Sci Rep. 2014 May 30;4:5080. doi: 10.1038/srep05080.
4
Incorporation of a selective sigma-2 receptor ligand enhances uptake of liposomes by multiple cancer cells.
Int J Nanomedicine. 2012;7:4473-85. doi: 10.2147/IJN.S31981. Epub 2012 Aug 13.
5
Gold nanocages: from synthesis to theranostic applications.
Acc Chem Res. 2011 Oct 18;44(10):914-24. doi: 10.1021/ar200061q. Epub 2011 Apr 29.
6
Use of multifunctional sigma-2 receptor ligand conjugates to trigger cancer-selective cell death signaling.
Cancer Res. 2012 Jan 1;72(1):201-9. doi: 10.1158/0008-5472.CAN-11-1354. Epub 2011 Nov 7.
7
Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents.
Nano Lett. 2005 Mar;5(3):473-7. doi: 10.1021/nl047950t.
8
Intracellular Delivery of a Planar DNA Origami Structure by the Transferrin-Receptor Internalization Pathway.
Small. 2016 May;12(19):2634-40. doi: 10.1002/smll.201503934. Epub 2016 Mar 31.
9
Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties.
ACS Nano. 2013 Jul 23;7(7):5675-83. doi: 10.1021/nn401905g. Epub 2013 May 22.
10
One-pot synthesis of polypeptide-gold nanoconjugates for in vitro gene transfection.
ACS Nano. 2012 Jan 24;6(1):111-7. doi: 10.1021/nn202939s. Epub 2011 Dec 5.
引用本文的文献
1
Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.
Nanomaterials (Basel). 2021 Mar 16;11(3):746. doi: 10.3390/nano11030746.
2
Phase-Change Materials for Controlled Release and Related Applications.
Adv Mater. 2020 Jun;32(25):e2000660. doi: 10.1002/adma.202000660. Epub 2020 May 8.
3
NO1, a New Sigma 2 Receptor/TMEM97 Fluorescent Ligand, Downregulates SOCE and Promotes Apoptosis in the Triple Negative Breast Cancer Cell Lines.
Cancers (Basel). 2020 Jan 21;12(2):257. doi: 10.3390/cancers12020257.
4
Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.
Nanoscale. 2017 Jan 26;9(4):1356-1392. doi: 10.1039/c6nr07315h.
5
Sigma receptors [σRs]: biology in normal and diseased states.
J Recept Signal Transduct Res. 2016 Aug;36(4):327-388. doi: 10.3109/10799893.2015.1015737. Epub 2015 Jun 9.
6
Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies.
Adv Healthc Mater. 2014 Aug;3(8):1283-91. doi: 10.1002/adhm.201400026. Epub 2014 Mar 26.
7
Research perspectives: gold nanoparticles in cancer theranostics.
Quant Imaging Med Surg. 2013 Dec;3(6):284-91. doi: 10.3978/j.issn.2223-4292.2013.12.02.
8
The σ2 receptor: a novel protein for the imaging and treatment of cancer.
J Med Chem. 2013 Sep 26;56(18):7137-60. doi: 10.1021/jm301545c. Epub 2013 Jun 18.
9
Ultrabright fluorescent mesoporous silica nanoparticles for prescreening of cervical cancer.
Nanomedicine. 2013 Nov;9(8):1255-62. doi: 10.1016/j.nano.2013.04.011. Epub 2013 May 9.
10
Characterization of spherulites as a lipidic carrier for low and high molecular weight agents.
Pharm Res. 2013 Jun;30(6):1525-35. doi: 10.1007/s11095-013-0990-y. Epub 2013 Apr 12.
本文引用的文献
1
Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site.
Nat Commun. 2011 Jul 5;2:380. doi: 10.1038/ncomms1386.
2
Gold nanocages: from synthesis to theranostic applications.
Acc Chem Res. 2011 Oct 18;44(10):914-24. doi: 10.1021/ar200061q. Epub 2011 Apr 29.
3
The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine.
Mol Cancer. 2010 Nov 22;9:298. doi: 10.1186/1476-4598-9-298.
4
Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands.
Curr Pharm Des. 2010;16(31):3519-37. doi: 10.2174/138161210793563365.
5
A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands.
ACS Nano. 2010 Oct 26;4(10):5887-96. doi: 10.1021/nn102055s.
6
Strategies in the design of nanoparticles for therapeutic applications.
Nat Rev Drug Discov. 2010 Aug;9(8):615-27. doi: 10.1038/nrd2591. Epub 2010 Jul 9.
7
Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands.
J Am Chem Soc. 2010 Jul 7;132(26):8848-9. doi: 10.1021/ja102635c.
8
Enhanced anticancer activity of multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers.
Chem Commun (Camb). 2010 Mar 7;46(9):1494-6. doi: 10.1039/b923560d. Epub 2009 Dec 23.
9
Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo.
Cent Nerv Syst Agents Med Chem. 2009 Sep;9(3):230-45. doi: 10.2174/1871524910909030230.
10
Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma.
J Transl Med. 2009 Mar 26;7:24. doi: 10.1186/1479-5876-7-24.
Zotero 插件